Oakworth Capital’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Oakworth Capital’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.8K	Hold	611	–	–	﹤0.01%	454
2026 Q1	$48.4K	Hold	611	–	–	﹤0.01%	452
2025 Q4	$50.2K	Hold	611	–	–	﹤0.01%	434
2025 Q3	$42.7K	Hold	611	–	–	﹤0.01%	457
2025 Q2	$39.2K	Hold	611	–	–	﹤0.01%	375
2025 Q1	$38.8K	Hold	611	–	–	﹤0.01%	384
2024 Q4	$40.6K	Hold	611	–	–	﹤0.01%	379
2024 Q3	$42.7K	Hold	611	–	–	﹤0.01%	372
2024 Q2	$39.6K	Hold	611	–	–	﹤0.01%	367
2024 Q1	$39.5K	Hold	611	–	–	﹤0.01%	343
2023 Q4	$40.2K	Hold	611	–	–	﹤0.01%	347
2023 Q3	$34.8K	Hold	611	–	–	﹤0.01%	338
2023 Q2	$37.4K	Hold	611	–	–	﹤0.01%	340
2023 Q1	$38.4K	Hold	611	–	–	﹤0.01%	326
2022 Q4	$38.8K	Hold	611	–	–	﹤0.01%	311
2022 Q3	$36K	Hold	611	–	–	﹤0.01%	329
2022 Q2	$35K	Hold	611	–	–	﹤0.01%	336
2022 Q1	$38K	Hold	611	–	–	﹤0.01%	328
2021 Q4	$44K	Hold	611	–	–	﹤0.01%	343
2021 Q3	$46K	Hold	611	–	–	﹤0.01%	324
2021 Q2	$47K	Hold	611	–	–	﹤0.01%	320
2021 Q1	$45K	Hold	611	–	–	0.01%	321
2020 Q4	$43K	Hold	611	–	–	0.01%	299
2020 Q3	$35K	Buy	+611	New	+$35.9K	0.01%	322

Other funds holding PBE

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

PIM

Penobscot Investment Management Boston, Massachusetts $1.46B AUM 32.32% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

NDSI

Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Oakworth Capital's PBE Position: Q2 2026 in Review

Oakworth Capital held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q2 2026 at 611 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

Oakworth Capital first reported a position in PBE in Q3 2020 and has held it in 24 quarters since. 31 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

Oakworth Capital held 611 shares of Invesco Biotechnology & Genome ETF worth $54.8K as of Q2 2026.
Oakworth Capital left its Invesco Biotechnology & Genome ETF share count unchanged in Q2 2026.
Invesco Biotechnology & Genome ETF made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #454 holding.
Oakworth Capital first reported a position in Invesco Biotechnology & Genome ETF in Q3 2020 and has held it in 24 quarters since.
31 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.